Accessibility Menu
 
Cipher Pharmaceuticals logo

Cipher Pharmaceuticals

(TSX) CPH

Current Price$18.80
Market Cap$475.29M
Since IPO (2004)+408%
5 Year+1,262%
1 Year+49%
1 Month+26%

Cipher Pharmaceuticals Financials at a Glance

Market Cap

$475.29M

Revenue (TTM)

$50.64M

Net Income (TTM)

$27.53M

EPS (TTM)

$1.46

P/E Ratio

12.57

Dividend

$0.00

Beta (Volatility)

0.52 (Low)

Price

$18.80

Volume

66,281

Open

$18.13

Previous Close

$18.80

Daily Range

$18.13 - $18.88

52-Week Range

$10.61 - $18.88

CPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cipher Pharmaceuticals

Industry

Pharmaceuticals

Employees

61

CEO

Craig Mull

Headquarters

Mississauga, ON L6H 0M2, CA

CPH Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

33%

Net Income Margin

54%

Return on Equity

24%

Return on Capital

13%

Return on Assets

18%

Earnings Yield

7.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$475.29M

Shares Outstanding

25.28M

Volume

66.28K

Short Interest

0.00%

Avg. Volume

32.29K

Financials (TTM)

Gross Profit

$33.77M

Operating Income

$16.80M

EBITDA

$16.80M

Operating Cash Flow

$30.25M

Capital Expenditure

$28.49K

Free Cash Flow

$30.22M

Cash & ST Invst.

$7.48M

Total Debt

$5.49M

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$12.41M

+4.9%

Gross Profit

$8.23M

+23.0%

Gross Margin

66.36%

N/A

Market Cap

$475.29M

N/A

Market Cap/Employee

$95.06M

N/A

Employees

5

N/A

Net Income

$13.52M

+304.2%

EBITDA

$4.27M

+131.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.98M

+108.7%

Accounts Receivable

$11.19M

-19.3%

Inventory

$8.18M

+41.1%

Long Term Debt

$5.21M

-87.1%

Short Term Debt

$288.47K

+1.9%

Return on Assets

17.63%

N/A

Return on Invested Capital

12.73%

N/A

Free Cash Flow

$8.84M

-0.4%

Operating Cash Flow

$8.87M

-0.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EDT.TOSpectral Medical Inc.
$1.42+0.00%
NGEN.VNervGen Pharma Corp.
$5.15+3.00%
TSND.TOTerrAscend Corp.
$0.94+3.30%
HITI.VHigh Tide Inc.
$3.22+2.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
TSLATesla
$360.59-0.05%

Questions About CPH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.